Sponsors / IVVD
IVVD

Invivyd, Inc.

Company identity checked against sources

Browse linked trials and recorded changes, or follow this company for updates.

Follow company
5Trials in this database
5Recorded changes · last 12 months
Partial coverageOnly the trials and history collected so far

Research sample: selected versions from May 2023 onward plus a preceding baseline where available. Only selected fields were retained; endpoint measures were truncated to 300 characters. This is not complete trial or sponsor history. Daily snapshots begin when collection starts.

Completion dates · Pro

Which trial dates moved later?

Pro summarizes how far estimated completion dates moved later and counts trials with edits to their main study measures, using the history available here. View Pro features

Included trials

Check company identity source
TrialSponsorPhaseStatusPrimary completion
Evaluation of ADG20 for the Treatment of Mild or Moderate COVID-19NCT04805671IVVDPhase 2, Phase 3Terminated2022-02-10Actual
Evaluation of ADG20 for the Prevention of COVID-19NCT04859517IVVDPhase 2, Phase 3Terminated2022-11-04Actual
A Study to Investigate the Prevention of COVID-19 WithVYD222 in Adults with Immune Compromise and in Participants Aged 12 Years or Older Who Are At Risk of Exposure to SARS-CoV-2NCT06039449IVVDPhase 3Completed2024-11-19Actual
Study of VYD2311 for the Prevention of COVID-19NCT07298434IVVDPhase 3Active not recruiting2026-08Estimated
Safety and Serum Virus Neutralizing Antibody Responses of VYD2311, a COVID-19 Vaccine, and Coadministered VYD2311 With a COVID-19 VaccineNCT07655180IVVDPhase 3Recruiting2026-08Estimated

Latest recorded trial changes